Technical Analysis for OSUR - OraSure Technologies, Inc.

Grade Last Price % Change Price Change
grade D 8.13 -0.97% -0.08
OSUR closed down 0.97 percent on Wednesday, November 13, 2019, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Down
See historical OSUR trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Doji - Bullish? Reversal 0.00%
Stochastic Reached Oversold Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.97%
Calm After Storm Range Contraction -0.97%

Older signals for OSUR ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
OraSure Technologies, Inc. develops, manufactures, and markets oral fluid diagnostic products and specimen collection devices using its proprietary oral fluid technologies. Its diagnostic products include tests that are performed on a rapid basis at the point of care; and tests, which are processed in a laboratory. The principal products comprise OraQuick ADVANCE HIV-1/2, OraQuick In-Home HIV Test, OraQuick HCV, OraSure QuickFlu rapid flu A&B test, OraSure, Oragene DX, Oragene DNA, Oragene DISCOVER, Oragene RNA, ORAcollect, OMNIgene DISCOVER, Performagene LIVESTOCK and Oragene ANIMAL, Intercept, MICRO-PLATE DOA Assays, Homogeneous DOA Assays, and professional and over-the-counter Cryosurgical Systems. In addition, the company, through its subsidiary, DNA Genotek Inc., manufactures and sell kits used to collect, stabilize, and store samples of genetic material for molecular testing in the academic research, clinical genetic testing, pharmacogenomics, personalized medicine, and animal and livestock genetics markets. Its OraGene DNA sample collection kit provides an all-in-one system for the collection, stabilization, and transportation of DNA from human saliva. Further, the company offers medical devices used for the removal of benign skin lesions by cryosurgery or freezing. Additionally, it sells certain immunoassay tests and reagents for insurance risk assessment, substance abuse testing, and forensic toxicology applications; an oral fluid Western blot HIV-1 confirmatory test for confirming positive HIV-1 test; and the FDA 510(k) cleared Q.E.D. rapid point-of-care saliva alcohol test. The company sells its products to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities in the United States and internationally. OraSure Technologies, Inc. was founded in 1979 and is based in Bethlehem, Pennsylvania.
Medicine Transportation Medical Tests HIV FDA Diagnostic Products HIV/Aids HCV Diagnosis Of Hiv/Aids
Is OSUR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 13.88
52 Week Low 6.35
Average Volume 605,203
200-Day Moving Average 9.0427
50-Day Moving Average 7.896
20-Day Moving Average 8.4625
10-Day Moving Average 8.57
Average True Range 0.3432
ADX 23.5
+DI 15.7105
-DI 18.4687
Chandelier Exit (Long, 3 ATRs ) 8.3004
Chandelier Exit (Short, 3 ATRs ) 8.8596
Upper Bollinger Band 8.9401
Lower Bollinger Band 7.9849
Percent B (%b) 0.15
BandWidth 11.287445
MACD Line 0.139
MACD Signal Line 0.2228
MACD Histogram -0.0838
Fundamentals Value
Market Cap 485.2 Million
Num Shares 59.7 Million
EPS 0.54
Price-to-Earnings (P/E) Ratio 15.06
Price-to-Sales 8.97
Price-to-Book 5.27
PEG Ratio 2.12
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.43
Resistance 3 (R3) 8.45 8.36 8.38
Resistance 2 (R2) 8.36 8.29 8.36 8.36
Resistance 1 (R1) 8.25 8.24 8.21 8.23 8.35
Pivot Point 8.16 8.16 8.14 8.16 8.16
Support 1 (S1) 8.05 8.09 8.01 8.03 7.91
Support 2 (S2) 7.96 8.04 7.96 7.90
Support 3 (S3) 7.85 7.96 7.88
Support 4 (S4) 7.83